融合基因anti-erbB2 scFv-Fc-CD28-CD3(ζ)的构建及真核表达

本研究利用SWISS-MODEL预测该融合蛋白的三级结构。利用PCR的方法分别从重组pPIC9k、重组pBullet和pSecTag2B上扩增出3段基因片段,即片段anti-erbB2 scFv(简称A)、片段Fc-CD28-CD3(ζ)(简称B)和信号肽序列(简称S)。利用SOE-PCR将3段序列连接形成融合基因片段S-A-B。经TA克隆扩增及鉴定后,将融合基因片段与逆转录病毒表达载体pLNCX相连构建重组真核表达载体,电转染人淋巴瘤T细胞株Jurkat,G418筛选后用流式细胞术检测融合蛋白稳定表达情况。经预测在anti-erbB2 scFv与Fc基因片段之间不加连接肽的融合蛋白,在三级结构上可形成更佳的功能构象。经PCR、酶切及测序鉴定均证实成功构建重组真核表达载体pLNCX/S-A-B(在A与B基因片段之间不加linker)。经流式细胞术检测,在转染的Jurkat细胞中融合蛋白表达率约为56.17%。本研究应用分子克隆的方法成功地构建了重组真核表达载体pLNCX/anti-erbB2 scFv-Fc-CD28-CD3(ζ),融合基因能够在淋巴瘤T细胞株中表达,为制备含该融合基因的原代T淋巴细胞,进行erbB2过表达肿瘤的靶向基因治疗研究奠定了实验基础。     

伪狂犬病病毒宿主关闭蛋白的基因克隆及结构分析

为研究伪狂犬病病毒 (pseudorabiesvires ,PRV)UL4 1基因编码的病毒宿主关闭蛋白 (VHS)的结构与功能 ,通过PCR扩增得到含UL4 1基因完整编码区的 1174bp片段 ,将该片段克隆到表达载体pGEX KG中GST下游 ,在大肠杆菌BL2 1(DE3)中实现了GST VHS融合蛋白的高效表达 .序列分析发现VHS蛋白具有 4个保守区 ,并且第 3个保守区与核酸内切酶结构域FEN 1(1A76 )高度同源 .PROSPECT软件预测的伪狂犬病病毒VHS蛋白三维结构中含有 10个α螺旋和 2 2个β折叠 ,与单纯疱疹病毒Ⅰ型的VHS蛋白三维结构十分相似 .     

多顺反子慢病毒载体介导编码基因在人胚胎干细胞中的表达

人胚胎干细胞的基因修饰对于干细胞在体外的调控及促进干细胞在治疗方面的应用具有很高价值.探讨了以艾滋病病毒-1为基础的慢病毒栽体转导人胚胎干细胞,表达2种或3种转移基因的可行性和功效.应用脑心肌炎病毒的内部核糖体进入住点(IRFS)序列和/或口蹄疫病毒(FMDV)裂解因子2A构建双顺反子和三顺反子慢病毒载体,绿色荧光蛋白(eGFP)和O<'6>-甲基鸟嘌呤-DNA-甲基转移酶作为检测基因.抗嘌呤基因(嘌呤-N-甲基转移酶;PAC)作为选择基因,转染人胚胎干细胞后经过嘌呤选择.通过流式细胞技术和蛋白印迹杂交方法检测eGFP和MGMT的表达.多基因慢病毒载体可以同时将2或3个基因转移到人胚胎干细胞.多顺反子慢病毒栽体转导人胚胎干细胞后经过嘌呤选择,可以使转移基因高效、均匀的表达,在人胚胎干细胞的基础和应用研究方面具有重要意义.     

人蛋白激酶CK2α′亚基在大肠杆菌中的克隆、表达及其重组蛋白的纯化与性质鉴定

通过RT PCR从HL 6 0细胞获得人蛋白激酶CK2α′亚基编码区cDNA ,将NdeⅠ HindⅢ双酶切的PCR产物和pT7 7表达载体进行定向克隆、细菌转化、电泳初筛和限制性酶切分析鉴定 .随机挑选阳性克隆进行DNA测序确证 ,筛选含与已知序列完全相符的重组质粒 (命名为pTCKA′) .将其转化BL2 1(DE3)菌 ,IPTG诱导后未见高效特异表达 .然后将人CK2α′cDNA亚克隆至GST融合蛋白表达载体 ,经同样转化和诱导步骤后可见一蛋白特异高效表达 .Western印迹结果证明 :该蛋白能与兔抗人CK2α′3 3 3 3 50 肽段抗血清发生特异性免疫反应 .采用GSH Sepharose 4B柱纯化 ,凝血酶酶切 ,最后从 4g细菌获 4 4mg纯化重组蛋白 .通过性质鉴定和酶动力学分析证明 :克隆、表达和纯化的重组蛋白是有生物学活性的人CK2α′亚基 .     

外源基因在耻垢分枝杆菌中表达效率的研究

将外源基因——日本血吸虫26K抗原(Schistosoma japonicum 26K antigen,Sj26GST)基因克隆到大肠杆菌-分枝杆菌穿梭质粒pBCG-2000中, 构建四个不同的表达载体, 研究了它们在耻垢分枝杆菌中的表达效率.首先将含人结核杆菌热休克蛋白70(heat shock protein, hsp70)启动子的质粒pMT-70用NcoⅠ切, 进行两种不同的修饰, 得到不同的SD序列, 将Sj26GST基因克隆进去; 再将含hsp70启动子和Sj26GST的基因片段克隆到pBCG-2000中, 筛选出不同SD序列、不同方向和不同拷贝数的分枝杆菌表达载体四个.所表达的天然重组Sj26GST在SDS-PAGE上分子质量为26 ku处可见明显的表达蛋白带.通过薄层扫描分析, 发现表达质粒中, 双拷贝启动子-外源基因组合表达效率最高, 是单拷贝组合的1.6倍.而不同的克隆方向和不同的SD序列(两者相差3个碱基)对表达效率的影响不明显.     

斜纹夜蛾GST基因的原核表达载体构建、融合蛋白表达及Northern印迹分析

谷胱甘肽-S-转移酶(GST)是生物体内重要的解毒酶系之一。根据斜纹夜蛾(Spodoptera litura)GST基因设计特异引物,从cDNA文库中扩增GST基因并克隆至pGEM-T载体,经鉴定后经SpeⅠ和EcoRⅠ双酶切后,与表达载体pPROEX HTb连接,转化感受态细胞E.coliDH5α,经PCR鉴定和双酶切鉴定得到阳性重组质粒pPROEX HTb-GST,在IPTG诱导下,获得融合蛋白的表达。经SDS-PAGE蛋白电泳鉴定,表达产物为25KD的GST融合蛋白。Northern杂交结果表明,2龄期斜纹夜蛾GST基因在mRNA水平上的表达量最大,3龄期次之,5龄期时的表达量最小。     

hBMP2转基因载体的构建及其在兔骨髓基质细胞中的表达

目的构建hBMP2真核表达载体pcDNA3-hBMP2,将其转染兔骨髓基质细胞(Marrow Stromal Cells,MSCs)并检测其表达效率。方法将hBMP2的cDNA构建于真核表达载体pcDNA3,形成重组真核表达载体pcDNA3-hBMP2,酶切鉴定后体外转染培养状态下的兔骨髓基质细胞,用原位杂交和免疫组织化学方法鉴定表达情况并用计算机图像分析系统测定其表达效率。结果pcDNA3-hBMP2载体酶切鉴定与预期片段相符,表明成功构建了pcDNA3-hBMP2转基因载体。用该载体转染兔骨髓基质细胞后获得了瞬时表达和稳定表达。结论载体pcDNA3-hBMP2可以在骨髓基质细胞中表达,为下一步将其用于转基因骨组织工程研究奠定基础。     

新城疫病毒F蛋白中两段七肽重复序列的克隆和表达

从新城疫病毒 (NDV)中国强毒株F4 8E9和弱毒株长春株F蛋白的cDNA中亚克隆出两段七肽重复序列(HeptadRepeatRegion ,HR1,HR2 ) ,将HR1和HR2分别插入表达载体pGEX 6p 1,在大肠杆菌BL2 1(DE3 )中表达 ,将与载体中的GST(GlutathioneS Trasferase)融合表达的可溶性融合蛋白用GST亲和层析柱纯化。纯化的融合蛋白用蛋白酶酶切后 ,先用GST亲和层析柱除去GST ,再加热进一步纯化。纯化的HR1和HR2质谱分析其分子量 ,结果表明 ,强株的HR1和HR2的分子量分别为 7 10 3kD和 6 3 0 1kD ,弱株的HR1和HR2的分子量分别为 7 10 7kD和6 3 0 9kD ,强弱株HR1和HR2的分子量都基本一致。本工作为研究HR1、HR2的结构以及它们在NDV与宿主细胞融合中的作用奠定了基础。     

GST/ AEP 融合蛋白原核表达载体的构建、表达及鉴定

目的：为进一步研究抗癫痫肽（And—epilepsy peptide,AEP）的抗痫机制及筛选其相关作用蛋白,进行GST／AEP融合蛋白原核表达载体的构建及融合蛋白的表达。方法：通过PCR基因扩增对AEP基因进行扩增,并将其克隆于谷胱甘肽-S-转移酶（GST）融合蛋白表达质粒pGEX-4T-1中,经酶切、序列鉴定分析后,用该重组质粒转化大肠杆菌B121（DE3）,经IPTG诱导获得表达,并采用Western Blot进行检测。结果：成功构建了AEP原核表达载体,并在大肠杆菌B121中获得表达。结论：成功构建了GST／AEP原核表达载体,并表达了GST／AEP融合蛋白。     

人GST-AWP1融合蛋白的原核表达及其抗体制备

为进一步研究人的一新蛋白———蛋白激酶C相关激酶 1相关蛋白 (AWP1)的结构、功能及与其相互作用的蛋白而进行GST AWP融合蛋白表达载体的构建、原核表达、纯化及其抗体的制备 .采用逆转录PCR(RT PCR)法从人ECV30 4内皮细胞中扩增AWP1cDNA编码区 ,并将其重组于谷胱甘肽硫转移酶 (GST)融合蛋白表达质粒pGEX KG中 .经酶切、序列鉴定分析后 ,用该重组质粒转化大肠杆菌BL2 1,并经异丙基 β D 硫代半乳糖苷 (IPTG)诱导产生GST AWP1融合蛋白 ,继而纯化获得了分子量约 5 6kD的融合蛋白 .将此融合蛋白免疫新西兰兔 ,经ELISA和Western印迹检测获得了效价高、免疫活性强的兔抗人多克隆抗体 .结果表明成功构建了GST AWP1融合蛋白表达载体 ,在大肠杆菌高效表达了GST AWP1融合蛋白 ,并获得高效多抗 ,为下阶段深入AWP1功能研究提供了重要的基础     

Effects of codon modification on human BMP2 gene expression in tobacco plants

Bone morphogenetic protein 2 (BMP2) has great potential in therapeutic applications. We are working on generating transgenic plants as a bioreactor to produce BMP2. We have studied the effects of codon optimization on the expression of human BMP2 (hBMP2) in tobacco plants. Three modified hBMP2 genes were transformed into tobacco under the control of either cauliflower mosaic virus 35S (CaMV35S) promoter or double-CaMV35S promoter plus alfalfa mosaic virus (AMV) enhancer. The fused β-glucuronidase (GUS) reporter gene was used to facilitate the assay of protein expression. The results indicated that codon optimization could increase the protein expression level obviously under CaMV35S promoter. However, under relatively stronger initiation condition (double-CaMV35S promoter plus AMV enhancer), only the gene with the lowest degree of codon optimization could increase the protein expression level. Our findings suggest that the action of codon optimization may be influenced by the factors of promoter strength and A+T content in tobacco plants.     

A novel expression vector, designated as pHisJM, for producing recombinant His-fusion proteins

Compared to glutathione S -transferase (GST), tagging with hexahistidine residues (His) has several merits: low levels of toxicity and immunogenicity, a smaller size and no electric charge. We have constructed a novel expression vector, designated as pHisJM (EMBL/GenBank/DDJB accession no. AB116367), for producing recombinant His-fusion proteins. This vector was constructed by replacing GST and multiple cloning site (MCS) cassettes in pGEX-5X-3 with those of hexahistidine and MCS derived from pRSET C vector. Human annexin IV (Anx IV) was used as target protein. His-Anx IV fusion protein was expressed using pHisJM and gave a 40 kDa band when immuno-stained with anti-His mAb or anti-Anx IV mAb as predicted. To compare expression efficiency, a Anx IV cDNA inserted-pHisJM or pGEX-5X-3 was transformed into Escherichia coli DH5alpha, JM109, BL21 and BL21(DE3). Using pHisJM, Anx IV protein was highly expressed in all cell strains. In addition to the merits of using His-tag, pHisJM has several advantages: 1) it has high expression efficiency; 2) it can be used in any Escherichia coli strain; and 3) it can be used in a single strain of Escherichia coli in all steps from plasmid construction to the expression of the target gene.     

重组人骨形成蛋白-3羧基端肽在大肠杆菌中表达及其诱骨活性

以双顺反子表达载体,在大肠杆菌中经ＩＰＴＧ诱导表达了人骨形成蛋白－３羧基端肽段（ｈＢＭＰ－３Ｃ）,表达量占菌体总蛋白量的１８．５％．目的蛋白为２５ｋＤ、含ｈＢＭＰ－３Ｃ端２１５个氨基酸残基组成的肽段,包括ｈＢＭＰ－３成熟肽和一部分前肽．表达产物以包涵体的形式存在,用含ＴｒｉｔｏｎＸ－１００的洗涤液和５ｍｏｌ／Ｌ以下脲溶液连续洗涤,可获得较高纯度的重组人骨形成蛋白－３Ｃ端肽．经复性处理成可溶性蛋白,植入小鼠肌肉内,第１４ｄ组织切片显示有软骨细胞和软骨基质形成,第２１ｄ可见成骨细胞和骨基质形成．将ｒｈＢＭＰ－３Ｃ与脱矿去免疫原性异种骨粒复合后作小鼠肌肉植入试验,２１ｄ组织切片上可见硬质骨形成．结果表明：大肠杆菌表达的ｈＢＭＰ－３Ｃ经复性后具有诱骨活性,糖基化并非ＢＭＰ－３活性所必需．     

密码子偏性对痘苗病毒载体表达效率影响的研究

为了研究密码子偏性对痘苗病毒载体表达效率的影响,分别采用痘苗病毒及其宿主细胞的优势密码子对绿色荧光蛋白基因进行改造,利用荧光、Western blot和FCM等方法分析其在痘苗病毒载体系统的表达水平。结果显示,全部采用痘苗病毒优势密码子(富含A T)和全部采用宿主细胞优势密码子(富含G C),以及部分使用宿主细胞优势密码子的三种绿色荧光蛋白基因都能够有效表达,表达水平相近,表明痘苗病毒载体对目的基因密码子的使用具有很好宽容性。为了探讨这种宽容性的机理,分别利用在胞核内和在胞浆内转录的质粒载体对不同密码子偏性的绿色荧光蛋白基因进行表达分析。结果显示,胞核内转录目的基因的pcDNA3质粒载体能有效表达富含G C的绿色荧光蛋白基因,不能有效表达富含A T的绿色荧光蛋白基因,而胞浆内转录目的基因的pSCA质粒载体能同样有效表达上述不同密码子偏性的目的基因。这些结果表明,位于胞浆内的富含A U的转录产物能够有效表达,细胞核内生成的富含A U的转录产物可能受核膜屏障或其它核内因素影响而不能有效表达。因此,胞浆内繁殖的特性是痘苗病毒载体具有密码子宽容性的主要原因。此研究为痘苗病毒载体和常用真核表达载体的选择使用提供了重要实验依据。     

霍乱毒素B亚单位基因（CtxB）的克隆及其表达

从霍乱弧菌中抽提基因组ＤＮＡ,用ＰＣＥＲ方法获取霍乱毒素Ｂ亚单位基因（ＣｔｘＢ）。序列分析结果表明,ＣｔｘＢ基因编码１２４个氨基酸,其中编码６２位Ｔｈｒ的密码子与文献报道有差异。将ＣｔｘＢ基因插入质粒ｐＧＥＸ－４Ｔ－２,构建ｐＧＥＸ－ＣＴＸＢ表达质粒,转化大肠相菌ＢＬ２１（ＤＥ３０,筛选表达菌株ＣＴＸＢ／ＢＬ２１。工程株经ＩＰＴＧ诱导表达,可产生大量的表达蛋白,经ＳＤＳ－ＰＡＧＥ分析,融合蛋白分子     

Determination of antigenic domain in GST fused major surface protein (Nc-p43) of Neospora caninum

The antigenic domain of the major surface protein (Nc-p43) of Neospora caninum was examined by polymerase chain reaction of its gene fragments and recombinant expression as GST fusion proteins. The fragments of Nc-p43 were as follow: a total open reading frame (OFR), T; OFR without signal sequence and C-terminal hydrophobic sequence, S; N-terminal 2/3 parts of S, A; C-terminal 2/3 parts, P; N-terminal 1/3 part, X; middle 1/3 part, Y; and C-terminal 1/3 part, Z, respectively. The DNA fragments were cloned into pGEX-4T vector. Recombinant plasmids transformed into Escherichia coli of BL21 pLysS (DE3) strain were induced to express GST or GST fused fragments of Nc-p43 such as 69 kDa protein for T, 66 kDa for S, 52 kDa for A, 53 kDa for P, and 40 kDa proteins for X, Y, and Z, respectively in SDS-PAGE. The Nc-p43 fragments of T, S, and P reacted with a bovine serum of neosporosis while those of A, X, Y, and Z together with GST did not in the western blot. These findings suggest that the antigenic domain of Nc-p43 of N. caninum may be localized in the C-terminal 2/3 parts. Together with A19 clone in SAG1 of Toxoplasma gondii (Nam et al., 1996), the P fragment of Nc-p43 could be used as efficient antigens to diagnose and differentiate those infections with both species.     

Cloning, sequence analysis, and heterologous expression of a β-mannanase gene from Bacillus subtilis Z-2

Mannanase, an extracellular enzyme that catalyzes the hydrolysis of hemicelluloses to produce oligosaccharides, has potential to be applied in food industries. In this study a mannanase gene from B. subtilis Z-2 was isolated through PCR screening of a genomic DNA library. The nucleotide sequence of the mannanase gene, man, contained an open reading frame of 1080 bp, which codes for a deduced 26 amino-acid signal peptide and a mature protein with a deduced molecular mass of 38 kDa. The man gene can both be expressed heterologously into the periplasm from the plasmid pET22b(+) containing an intact signal peptide (pET-NdeI18) or the pelB signal peptide of the pET22b(+)vector (pET-NcoI3). Escherichia coli BL21 (DE3) containing pET-NcoI3 secreted about twice as much mannanase as that harboring pET-NdeI18. The E. coli DH5α expression of man was under the control of the lac promoter in the pRK415 vector; it was much more effective when the Shine Dalgarno (SD) sequence was changed from GGGGAG to AAGGAG and the start codon was changed from TTG to ATG, respectively. These results suggest that genetic modification of the SD sequence and start codon is practical for a high-level mannanase expression in different bacterial strains. Published in Russian in Molekulyarnaya Biologiya, 2006, Vol. 40, No. 3, pp. 418–424. This article was submitted by the authors in English.     

鼻咽癌侯选抑瘤基因BRD7原核表达载体的构建及其表达

BRD7基因是一个鼻咽癌侯选抑瘤基因,为了构建BRD7基因的原核表达载体并使其在大肠杆菌得到表达,设计了带有SalⅠ,NotⅠ酶切位点的引物,以已构建好的质粒pGEM-T Easy/BRD7为模板,用PCR扩增出BRD7基因的完整阅读框架,并用SalⅠ,NotⅠ酶切PCR产物和原核表达载体PGEX-4T-2,然后用T4 DNA连接酶将其连接,得到重组表达质粒PGEX-4T-2/BRD7,经双酶切鉴定和测序验证,表达载体构建正确.重组表达质粒转化感受态大肠杆菌Jm105后用IPTG诱导,成功表达了一分子质量约为90 ku的融合蛋白;37℃诱导4 h后,SDS-聚丙烯酰胺凝胶(PAGE)电泳后,经扫描分析该融合蛋白产量占菌体蛋白总量28.48%, 蛋白质印迹(Western-blot)证实了该融合蛋白的表达获得成功.这为BRD7基因的蛋白纯化及抗体制备,进一步开展其功能研究奠定了基础.     

ARTIFICIAL SYNTHESIS OF SWINE HEPCIDIN GENE AND EXPRESSION IN Pichia pastoris

In order to express swine hepcidin gene in Pichia pastoris, a DNA fragment coding hepcidin gene was synthesized with adaptation to yeast codon usage of highly expressed genes. A Kex2 signal cleavage site was fused in the 5′ end of the DNA fragment for getting a peptide with the same N-end as native hepcidin. The 96-bp DNA fragment was ligated into the expression plasmid of pGAPZaA to construct pGAPZaA-hepcidin vector, which was transferred into P. pastoris (X33) to express hepcidin gene for extracellular secretion of protein at 86 µg/mL. A band of 2.76 kD molecular mass was detected by Tricine sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) analysis. Through antibacterial assay, the expressed hepcidin displayed obvious antibacterial activity. The minimal inhibitory concentration (MIC) was 5.38 and 2.69 µg/mL for Staphylococcus aureus and Bacillus subtilis prolification inhibitions, respectively.     

抗虫杀菌融合基因表达载体的构建及微束激光转化植物研究

将苏云金芽孢杆菌伴孢晶体蛋白的基因(Bacillus thuringiesis,简称Bt)通过甘氨酸接头(Gly4Ser)3与一种人工合成的抗菌肽(antimicrobial peptides,AMP)基因与相融合,编码一种新的杀虫,并具有抗菌的蛋白。把融合基因(NAMP-Bt)连接到原核表达载体pET-28a和植物表达载体pBI-121上,经过限制性酶切分析和PCR鉴定,结果表明含有融合基因的原核和真核重组表达质粒均已构建成功,并将该融合基因转入烟草,已获得抗性小植株。